US3993073A
(en)
*
|
1969-04-01 |
1976-11-23 |
Alza Corporation |
Novel drug delivery device
|
US3896819A
(en)
*
|
1969-04-01 |
1975-07-29 |
Alejandro Zaffaroni |
IUD having a replenishing drug reservoir
|
US3854480A
(en)
*
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
US3797494A
(en)
*
|
1969-04-01 |
1974-03-19 |
Alza Corp |
Bandage for the administration of drug by controlled metering through microporous materials
|
US3710795A
(en)
*
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
US3964482A
(en)
*
|
1971-05-17 |
1976-06-22 |
Alza Corporation |
Drug delivery device
|
US3731683A
(en)
*
|
1971-06-04 |
1973-05-08 |
Alza Corp |
Bandage for the controlled metering of topical drugs to the skin
|
US3742951A
(en)
*
|
1971-08-09 |
1973-07-03 |
Alza Corp |
Bandage for controlled release of vasodilators
|
US3996934A
(en)
*
|
1971-08-09 |
1976-12-14 |
Alza Corporation |
Medical bandage
|
US3993071A
(en)
*
|
1971-09-09 |
1976-11-23 |
Alza Corporation |
Bioerodible ocular device
|
US3960150A
(en)
*
|
1971-09-09 |
1976-06-01 |
Alza Corporation |
Bioerodible ocular device
|
US3986510A
(en)
*
|
1971-09-09 |
1976-10-19 |
Alza Corporation |
Bioerodible ocular device
|
US3981303A
(en)
*
|
1971-09-09 |
1976-09-21 |
Alza Corporation |
Bioerodible ocular device
|
US3807398A
(en)
*
|
1972-09-19 |
1974-04-30 |
B Grucza |
Ocular implant
|
US3961628A
(en)
*
|
1974-04-10 |
1976-06-08 |
Alza Corporation |
Ocular drug dispensing system
|
US3993072A
(en)
*
|
1974-08-28 |
1976-11-23 |
Alza Corporation |
Microporous drug delivery device
|
US3951622A
(en)
*
|
1974-12-04 |
1976-04-20 |
Wilk Immanuel J |
Time release perfume method and device
|
DE2647581A1
(de)
*
|
1976-10-21 |
1978-04-27 |
Henkel Kgaa |
Blisterpackung
|
DE2650306A1
(de)
*
|
1976-11-02 |
1978-05-03 |
Merck Patent Gmbh |
Antibakteriell wirkender wundverband und verfahren zu seiner herstellung
|
US4201211A
(en)
*
|
1977-07-12 |
1980-05-06 |
Alza Corporation |
Therapeutic system for administering clonidine transdermally
|
US4286592A
(en)
*
|
1980-02-04 |
1981-09-01 |
Alza Corporation |
Therapeutic system for administering drugs to the skin
|
US4336243A
(en)
*
|
1980-08-11 |
1982-06-22 |
G. D. Searle & Co. |
Transdermal nitroglycerin pad
|
US5286748A
(en)
*
|
1981-01-05 |
1994-02-15 |
Eby Iii George A |
General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity
|
AU550098B2
(en)
*
|
1981-05-02 |
1986-03-06 |
Smith & Nephew Associated Companies Plc |
Sterile dressing
|
US4834979A
(en)
*
|
1981-06-29 |
1989-05-30 |
Alza Corporation |
Medical bandage for administering beneficial drug
|
US4725272A
(en)
*
|
1981-06-29 |
1988-02-16 |
Alza Corporation |
Novel bandage for administering beneficial drug
|
US4925671A
(en)
*
|
1981-11-24 |
1990-05-15 |
Flexcon Company, Inc. |
Silicone pressure sensitive adhesive and uses
|
US4460371A
(en)
*
|
1981-11-24 |
1984-07-17 |
Dennison Manufacturing Company |
Silicone pressure sensitive adhesive and uses
|
US4435180A
(en)
|
1982-05-25 |
1984-03-06 |
Alza Corporation |
Elastomeric active agent delivery system and method of use
|
IN157223B
(cs)
*
|
1982-07-16 |
1986-02-15 |
Central Wechsel Creditbank |
|
JPS5948409A
(ja)
*
|
1982-09-10 |
1984-03-19 |
Teikoku Seiyaku Kk |
矯正的歯牙移動促進剤
|
US4608249A
(en)
*
|
1982-11-02 |
1986-08-26 |
Nitto Electric Industrial Co., Ltd. |
Hydrophilic therapeutic material
|
DE3315272C2
(de)
*
|
1983-04-27 |
1986-03-27 |
Lohmann Gmbh & Co Kg, 5450 Neuwied |
Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
|
US4563184A
(en)
*
|
1983-10-17 |
1986-01-07 |
Bernard Korol |
Synthetic resin wound dressing and method of treatment using same
|
US4615697A
(en)
*
|
1983-11-14 |
1986-10-07 |
Bio-Mimetics, Inc. |
Bioadhesive compositions and methods of treatment therewith
|
US4795436A
(en)
*
|
1983-11-14 |
1989-01-03 |
Bio-Mimetics, Inc. |
Bioadhesive composition and method of treatment therewith
|
US5364628A
(en)
*
|
1985-05-31 |
1994-11-15 |
Sandoz Ltd. |
Pharmaceutical compositions
|
EP0156080B2
(en)
*
|
1984-03-05 |
1993-10-20 |
Nitto Denko Corporation |
Percutaneous absorption type adhesive pharmaceutical preparation
|
FR2562800A1
(fr)
*
|
1984-04-11 |
1985-10-18 |
Fournier Laboratoires |
Dispositif pour l'administration percutanee de medicaments
|
US4725439A
(en)
*
|
1984-06-29 |
1988-02-16 |
Alza Corporation |
Transdermal drug delivery device
|
US4704282A
(en)
*
|
1984-06-29 |
1987-11-03 |
Alza Corporation |
Transdermal therapeutic system having improved delivery characteristics
|
EP0186660A4
(en)
*
|
1984-07-07 |
1987-01-22 |
Flexcon Co Inc |
PRESSURE SENSITIVE SILICONE ADHESIVE AND USES THEREOF.
|
US4649075A
(en)
*
|
1984-08-09 |
1987-03-10 |
Leonora Jost |
Transdermal and transmucosal vortexed foam devices and the method of making
|
US4568343A
(en)
*
|
1984-10-09 |
1986-02-04 |
Alza Corporation |
Skin permeation enhancer compositions
|
US4638043A
(en)
*
|
1984-11-13 |
1987-01-20 |
Thermedics, Inc. |
Drug release system
|
US4614787A
(en)
*
|
1984-11-13 |
1986-09-30 |
Thermedics, Inc. |
Drug dispensing wound dressing
|
USRE32991E
(en)
*
|
1984-11-13 |
1989-07-18 |
Thermedics, Inc. |
Drug dispensing wound dressing
|
US4727868A
(en)
*
|
1984-11-13 |
1988-03-01 |
Thermedics, Inc. |
Anisotropic wound dressing
|
US4751133A
(en)
*
|
1984-11-13 |
1988-06-14 |
Thermedics, Inc. |
Medical patches and processes for producing same
|
US4880690A
(en)
*
|
1984-11-13 |
1989-11-14 |
Thermedics, Inc. |
Perfume patch
|
US4752478A
(en)
*
|
1984-12-17 |
1988-06-21 |
Merck & Co., Inc. |
Transdermal system for timolol
|
US4597961A
(en)
*
|
1985-01-23 |
1986-07-01 |
Etscorn Frank T |
Transcutaneous application of nicotine
|
JPS61280426A
(ja)
*
|
1985-06-04 |
1986-12-11 |
Ikeda Mohandou:Kk |
消炎鎮痛用貼付剤
|
EP0252076A1
(en)
*
|
1985-12-12 |
1988-01-13 |
Flexcon Company, Inc. |
Transdermal methods and adhesives
|
US4666441A
(en)
*
|
1985-12-17 |
1987-05-19 |
Ciba-Geigy Corporation |
Multicompartmentalized transdermal patches
|
US5204339A
(en)
*
|
1986-01-31 |
1993-04-20 |
Whitby Research, Inc. |
Penetration enhancers for transdermal delivery of systemic agents
|
CA1293192C
(en)
*
|
1986-01-31 |
1991-12-17 |
James V. Peck |
Compositions comprising 1-substituted azacycloalkanes
|
US4764378A
(en)
*
|
1986-02-10 |
1988-08-16 |
Zetachron, Inc. |
Buccal drug dosage form
|
US4743249A
(en)
*
|
1986-02-14 |
1988-05-10 |
Ciba-Geigy Corp. |
Dermal and transdermal patches having a discontinuous pattern adhesive layer
|
DE3770836D1
(de)
*
|
1986-02-14 |
1991-07-25 |
Ciba Geigy Ag |
Dermale und transdermale therapeutische systeme mit musterfoermig aufgetragener klebschicht, sowie verfahren zur dessen herstellung.
|
US4797284A
(en)
*
|
1986-03-12 |
1989-01-10 |
Merck & Co., Inc. |
Transdermal drug delivery system
|
US5560922A
(en)
*
|
1986-05-30 |
1996-10-01 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
|
CA1272922A
(en)
*
|
1986-06-03 |
1990-08-21 |
Peter William Berry |
Drug delivery device, its preparation and use
|
EP0249475A3
(en)
*
|
1986-06-13 |
1989-10-11 |
Alza Corporation |
Delayed percutaneous delivery
|
ATE71287T1
(de)
*
|
1986-06-13 |
1992-01-15 |
Alza Corp |
Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
|
DE3762480D1
(de)
*
|
1986-08-23 |
1990-06-07 |
Arno W Latzke |
Mittel zur applikation von transdermal resorbierbaren wirkstoffen.
|
USRE37934E1
(en)
|
1986-08-28 |
2002-12-10 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system
|
US6126963A
(en)
*
|
1986-08-28 |
2000-10-03 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
US5820876A
(en)
*
|
1986-08-28 |
1998-10-13 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system
|
US6139868A
(en)
*
|
1986-08-28 |
2000-10-31 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
JPH0794384B2
(ja)
*
|
1986-09-01 |
1995-10-11 |
帝国製薬株式会社 |
徐放性口腔内用製剤
|
US5196202A
(en)
*
|
1986-09-01 |
1993-03-23 |
Teikoku Seiyaku Kabushiki Kaisha |
Sustained release dosage form
|
US4938759A
(en)
|
1986-09-02 |
1990-07-03 |
Alza Corporation |
Transdermal delivery device having a rate controlling adhesive
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US5344656A
(en)
*
|
1986-09-12 |
1994-09-06 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
CH672888A5
(cs)
*
|
1986-11-07 |
1990-01-15 |
Mepha Ag |
|
IL84498A0
(en)
*
|
1986-11-20 |
1988-04-29 |
Ciba Geigy Ag |
User-activated transdermal therapeutic system
|
FR2607003B1
(fr)
*
|
1986-11-20 |
1993-01-15 |
Marchandise Jean |
Carte cutanee homeopathique
|
US4909244B1
(en)
*
|
1986-11-26 |
1994-07-05 |
Kendall & Co |
Hydrogel wound dressing
|
US5322695A
(en)
*
|
1987-01-09 |
1994-06-21 |
Hercon Laboratories Corporation |
Moisture-vapor-permeable dressing
|
US4917688A
(en)
*
|
1987-01-14 |
1990-04-17 |
Nelson Research & Development Co. |
Bandage for transdermal delivery of systemically-active drug
|
US4865848A
(en)
*
|
1987-02-26 |
1989-09-12 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4746515A
(en)
*
|
1987-02-26 |
1988-05-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolaurate
|
US4940586A
(en)
*
|
1987-02-26 |
1990-07-10 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4900555A
(en)
*
|
1987-02-26 |
1990-02-13 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4816258A
(en)
*
|
1987-02-26 |
1989-03-28 |
Alza Corporation |
Transdermal contraceptive formulations
|
US4788062A
(en)
*
|
1987-02-26 |
1988-11-29 |
Alza Corporation |
Transdermal administration of progesterone, estradiol esters, and mixtures thereof
|
US5071656A
(en)
*
|
1987-03-05 |
1991-12-10 |
Alza Corporation |
Delayed onset transdermal delivery device
|
US5118509A
(en)
*
|
1987-03-09 |
1992-06-02 |
Alza Corporation |
Inducing skin tolerance to a sensitizing drug
|
US5000956A
(en)
*
|
1987-03-09 |
1991-03-19 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
US5049387A
(en)
*
|
1987-03-09 |
1991-09-17 |
Alza Corporation |
Inducing skin tolerance to a sensitizing drug
|
US5077054A
(en)
*
|
1987-03-09 |
1991-12-31 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
US5171576A
(en)
*
|
1987-03-09 |
1992-12-15 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
IL86170A
(en)
*
|
1987-05-01 |
1992-12-01 |
Elan Transdermal Ltd |
Preparations and compositions comprising nicotine for percutaneous administration
|
HU197519B
(en)
*
|
1987-06-22 |
1989-04-28 |
Biogal Gyogyszergyar |
Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
|
US4764379A
(en)
*
|
1987-08-24 |
1988-08-16 |
Alza Corporation |
Transdermal drug delivery device with dual permeation enhancers
|
US4820720A
(en)
*
|
1987-08-24 |
1989-04-11 |
Alza Corporation |
Transdermal drug composition with dual permeation enhancers
|
US5059189A
(en)
*
|
1987-09-08 |
1991-10-22 |
E. R. Squibb & Sons, Inc. |
Method of preparing adhesive dressings containing a pharmaceutically active ingredient
|
US4879275A
(en)
*
|
1987-09-30 |
1989-11-07 |
Nelson Research & Development Co. |
Penetration enhancers for transdermal delivery of systemic agent
|
US4920101A
(en)
*
|
1987-09-30 |
1990-04-24 |
Nelson Research & Development Co. |
Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
|
US4839174A
(en)
*
|
1987-10-05 |
1989-06-13 |
Pharmetrix Corporation |
Novel transdermal nicotine patch
|
US4943435A
(en)
*
|
1987-10-05 |
1990-07-24 |
Pharmetrix Corporation |
Prolonged activity nicotine patch
|
US4959208A
(en)
*
|
1987-10-19 |
1990-09-25 |
Ppg Industries, Inc. |
Active agent delivery device
|
US5071645A
(en)
*
|
1987-10-19 |
1991-12-10 |
Ppg Industries, Inc. |
Process of producing an active agent delivery device
|
US5035886A
(en)
*
|
1987-10-19 |
1991-07-30 |
Ppg Industries, Inc. |
Active agent delivery device
|
US4917895A
(en)
*
|
1987-11-02 |
1990-04-17 |
Alza Corporation |
Transdermal drug delivery device
|
US4837027A
(en)
*
|
1987-11-09 |
1989-06-06 |
Alza Corporation |
Transdermal drug delivery device
|
US4812305A
(en)
*
|
1987-11-09 |
1989-03-14 |
Vocal Rodolfo S |
Well medicine strip
|
US4781924A
(en)
|
1987-11-09 |
1988-11-01 |
Alza Corporation |
Transdermal drug delivery device
|
US4863738A
(en)
*
|
1987-11-23 |
1989-09-05 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monooleate
|
US5068226A
(en)
*
|
1987-12-07 |
1991-11-26 |
Cyclex, Inc. |
Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
|
US4979946A
(en)
*
|
1987-12-14 |
1990-12-25 |
The Kendall Company |
Environmental absorbent dressing
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
GB2232892B
(en)
*
|
1988-02-23 |
1991-07-24 |
John Mark Tucker |
Occlusive body for administering a physiologically active substance
|
GB8804164D0
(en)
*
|
1988-02-23 |
1988-03-23 |
Tucker J M |
Bandage for administering physiologically active compound
|
US5223261A
(en)
*
|
1988-02-26 |
1993-06-29 |
Riker Laboratories, Inc. |
Transdermal estradiol delivery system
|
US4885154A
(en)
*
|
1988-03-01 |
1989-12-05 |
Alza Corporation |
Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
|
US4877618A
(en)
*
|
1988-03-18 |
1989-10-31 |
Reed Jr Fred D |
Transdermal drug delivery device
|
US4900552A
(en)
*
|
1988-03-30 |
1990-02-13 |
Watson Laboratories, Inc. |
Mucoadhesive buccal dosage forms
|
US4840796A
(en)
*
|
1988-04-22 |
1989-06-20 |
Dow Corning Corporation |
Block copolymer matrix for transdermal drug release
|
US4951657A
(en)
*
|
1988-04-22 |
1990-08-28 |
Dow Corning Corporation |
Heat sealable membrane for transdermal drug release
|
US4942037A
(en)
*
|
1988-06-02 |
1990-07-17 |
Merck & Co., Inc. |
Transdermal delivery systems
|
US5378730A
(en)
*
|
1988-06-09 |
1995-01-03 |
Alza Corporation |
Permeation enhancer comprising ethanol and monoglycerides
|
US5641504A
(en)
*
|
1988-06-09 |
1997-06-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolinoleate
|
US5004610A
(en)
*
|
1988-06-14 |
1991-04-02 |
Alza Corporation |
Subsaturated nicotine transdermal therapeutic system
|
US4985016A
(en)
*
|
1989-02-15 |
1991-01-15 |
Alza Corporation |
Intravenous system for delivering a beneficial agent
|
US4969871A
(en)
*
|
1989-02-15 |
1990-11-13 |
Alza Corporation |
Intravenous system for delivering a beneficial agent
|
US5250028A
(en)
*
|
1989-02-15 |
1993-10-05 |
Alza Corporation |
Intravenous system for delivering a beneficial agent using permeability enhancers
|
US5045059A
(en)
*
|
1989-02-15 |
1991-09-03 |
Alza Corporation |
Intravenous system for delivering a beneficial agent
|
US5059426A
(en)
*
|
1989-03-22 |
1991-10-22 |
Cygnus Therapeutic Systems |
Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
|
US5053227A
(en)
*
|
1989-03-22 |
1991-10-01 |
Cygnus Therapeutic Systems |
Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
|
US4973468A
(en)
*
|
1989-03-22 |
1990-11-27 |
Cygnus Research Corporation |
Skin permeation enhancer compositions
|
US5788983A
(en)
*
|
1989-04-03 |
1998-08-04 |
Rutgers, The State University Of New Jersey |
Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
|
US4956171A
(en)
*
|
1989-07-21 |
1990-09-11 |
Paco Pharmaceutical Services, Inc. |
Transdermal drug delivery using a dual permeation enhancer and method of performing the same
|
US5217718A
(en)
*
|
1989-08-18 |
1993-06-08 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
US5124157A
(en)
*
|
1989-08-18 |
1992-06-23 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
US5230896A
(en)
*
|
1989-10-12 |
1993-07-27 |
Warner-Lambert Company |
Transdermal nicotine delivery system
|
JP2865422B2
(ja)
*
|
1989-10-23 |
1999-03-08 |
セラテック,インコーポレイテッド |
イオン浸透療法装置および速度調整膜を用いた方法
|
DE3939703C2
(de)
*
|
1989-12-01 |
1998-07-02 |
Boehringer Ingelheim Kg |
Verbesserte transdermale Applikation von pharmakologisch aktiven Verbindungen
|
US5508038A
(en)
*
|
1990-04-16 |
1996-04-16 |
Alza Corporation |
Polyisobutylene adhesives for transdermal devices
|
US5160741A
(en)
*
|
1990-07-06 |
1992-11-03 |
Alza Corporation |
Reduction or prevention of skin irritation by drugs
|
US5130139A
(en)
*
|
1990-07-06 |
1992-07-14 |
Alza Corporation |
Reduction or prevention of skin irritation by drugs
|
US5120545A
(en)
*
|
1990-08-03 |
1992-06-09 |
Alza Corporation |
Reduction or prevention of sensitization to drugs
|
US5149539A
(en)
*
|
1990-08-03 |
1992-09-22 |
Alza Corporation |
Reduction or prevention of sensitization to drugs
|
US5173302A
(en)
*
|
1990-09-28 |
1992-12-22 |
Medtronic, Inc. |
Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
|
US5314694A
(en)
*
|
1990-10-29 |
1994-05-24 |
Alza Corporation |
Transdermal formulations, methods and devices
|
US5512292A
(en)
*
|
1990-10-29 |
1996-04-30 |
Alza Corporation |
Transdermal contraceptive formulations methods and devices
|
JPH06502419A
(ja)
*
|
1990-10-29 |
1994-03-17 |
アルザ・コーポレーション |
経皮避妊製剤、方法及びデバイス
|
US5198223A
(en)
*
|
1990-10-29 |
1993-03-30 |
Alza Corporation |
Transdermal formulations, methods and devices
|
US5320850A
(en)
*
|
1990-10-29 |
1994-06-14 |
Alza Corporation |
Transdermal delivery of the gestogen ST-1435 and devices therefor
|
US5633009A
(en)
*
|
1990-11-28 |
1997-05-27 |
Sano Corporation |
Transdermal administration of azapirones
|
US5240917A
(en)
*
|
1991-04-03 |
1993-08-31 |
Keimowitz Rudolph M |
Suppression of thromboxane levels by percutaneous administration of aspirin
|
US5402777A
(en)
*
|
1991-06-28 |
1995-04-04 |
Alza Corporation |
Methods and devices for facilitated non-invasive oxygen monitoring
|
US5203768A
(en)
*
|
1991-07-24 |
1993-04-20 |
Alza Corporation |
Transdermal delivery device
|
US5464387A
(en)
*
|
1991-07-24 |
1995-11-07 |
Alza Corporation |
Transdermal delivery device
|
US5273756A
(en)
*
|
1991-08-23 |
1993-12-28 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
|
US5273755A
(en)
*
|
1991-08-23 |
1993-12-28 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
|
US5234690A
(en)
*
|
1991-08-23 |
1993-08-10 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
|
US5189986A
(en)
*
|
1991-09-23 |
1993-03-02 |
Alza Corporation |
Veterinary transdermal active agent delivery device
|
CA2116036A1
(en)
*
|
1991-10-18 |
1993-04-29 |
F. Eugene Yates |
Device for the transdermal administration of melatonin
|
US5364634A
(en)
*
|
1991-11-08 |
1994-11-15 |
Southwest Research Institute |
Controlled-release PH sensitive capsule and adhesive system and method
|
HRP921157A2
(en)
*
|
1991-12-20 |
1994-10-31 |
Lohmann Therapie Syst Lts |
Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy
|
US5268179A
(en)
*
|
1992-02-14 |
1993-12-07 |
Ciba-Geigy Corporation |
Ultrasonically sealed transdermal drug delivery systems
|
JP3786684B2
(ja)
*
|
1992-05-13 |
2006-06-14 |
アルザ・コーポレーション |
オキシブチニンの経皮投与
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
US6071896A
(en)
*
|
1992-06-16 |
2000-06-06 |
Gundersen Clinic, Ltd. |
Suppression of thromboxane levels by percutaneous administration of aspirin
|
DE4305881C1
(de)
*
|
1993-02-26 |
1994-03-03 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit Wirkstoffen, welche Stichoxid-Quellen darstellen, Verfahren zu seiner Herstellung sowie seine Verwendung
|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6287598B1
(en)
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US5451407A
(en)
*
|
1993-06-21 |
1995-09-19 |
Alza Corporation |
Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
|
WO1995001167A2
(en)
*
|
1993-06-25 |
1995-01-12 |
Alza Corporation |
Incorporating poly-n-vinyl amide in a transdermal system
|
EP0707465A4
(en)
*
|
1993-07-08 |
1997-04-16 |
Cygnus Therapeutic Systems |
MONOLITHIC MATRIX TRANSDERMAL DELIVERY SYSTEM
|
US5691377A
(en)
*
|
1993-07-30 |
1997-11-25 |
University Of Maryland Eastern Shore And University Of Maryland College Park |
Use of N-methyl-aspartic acid for enhancing growth and altering body composition
|
KR960704579A
(ko)
*
|
1993-09-29 |
1996-10-09 |
에드워드 엘. 만델 |
옥시부티닌용 모노글리세리드/락테이트 에스테르 투과 촉진제(Monoglyceride/lactate Ester Permeation Enhancer for Oxybutynin)
|
JPH07157424A
(ja)
*
|
1993-12-03 |
1995-06-20 |
Lintec Corp |
局所麻酔用ゲル製剤
|
DE4341444C2
(de)
*
|
1993-12-04 |
1996-03-14 |
Lohmann Therapie Syst Lts |
Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
|
US5962011A
(en)
*
|
1993-12-06 |
1999-10-05 |
Schering-Plough Healthcare Products, Inc. |
Device for delivery of dermatological ingredients
|
DE4343838C2
(de)
*
|
1993-12-22 |
1998-07-09 |
Lohmann Therapie Syst Lts |
Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
|
DE4403709A1
(de)
*
|
1994-02-07 |
1995-08-10 |
Lohmann Therapie Syst Lts |
Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
|
US5536263A
(en)
*
|
1994-03-30 |
1996-07-16 |
Lectec Corporation |
Non-occulusive adhesive patch for applying medication to the skin
|
JPH09512006A
(ja)
*
|
1994-04-13 |
1997-12-02 |
チバ−ガイギー アクチェンゲゼルシャフト |
時間的に調節された薬物供給システム
|
US5490415A
(en)
*
|
1994-04-15 |
1996-02-13 |
Pharmetrix Corporation |
Diffusion test apparatus and method
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
US5498417A
(en)
*
|
1994-05-12 |
1996-03-12 |
Coating Sciences, Inc. |
Transdermal delivery of appetite suppressant drug
|
DE4421433C1
(de)
*
|
1994-06-18 |
1995-06-08 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung
|
AU2703795A
(en)
*
|
1994-06-23 |
1996-01-19 |
Procter & Gamble Company, The |
Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
JP3576608B2
(ja)
*
|
1994-11-15 |
2004-10-13 |
日東電工株式会社 |
貼付剤および貼付製剤
|
AU695170B2
(en)
*
|
1994-12-21 |
1998-08-06 |
Theratech, Inc. |
Transdermal delivery system with adhesive overlay and peel seal disc
|
US6344211B1
(en)
|
1994-12-24 |
2002-02-05 |
Lts Lohmann Therapie-Systeme Gmbh |
Transdermal absorption of active substances from subcooled melts
|
DE4446600A1
(de)
|
1994-12-24 |
1996-06-27 |
Lohmann Therapie Syst Lts |
Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
|
US5662928A
(en)
*
|
1995-04-21 |
1997-09-02 |
Ciba-Geigy Corporation |
Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system
|
US5882676A
(en)
*
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US6572879B1
(en)
*
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
US5840327A
(en)
*
|
1995-08-21 |
1998-11-24 |
Alza Corporation |
Transdermal drug delivery device having enhanced adhesion
|
AU7286996A
(en)
*
|
1995-10-18 |
1997-05-07 |
Ciba-Geigy Ag |
Thermopile powered transdermal drug delivery device
|
US6238700B1
(en)
|
1995-12-01 |
2001-05-29 |
Alza Corporation |
Method for preventing crystal formation in a dispersion of a liquid in a matrix
|
EP0863751B1
(en)
|
1995-12-01 |
2001-10-24 |
Alza Corporation |
Improved method for preventing crystal formation in a dispersion of a liquid in a matrix
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
US6007837A
(en)
*
|
1996-07-03 |
1999-12-28 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US5942243A
(en)
*
|
1996-11-12 |
1999-08-24 |
Polytherapeutics, Inc. |
Mucoadhesive compositions for administration of biologically active agents to animal tissue
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
US6174545B1
(en)
|
1997-07-01 |
2001-01-16 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
TR200101783T2
(tr)
|
1998-12-18 |
2002-05-21 |
Alza Corporation |
Saydam transdermal nikotin iletme düzenekleri.
|
PT1163019E
(pt)
*
|
1999-03-25 |
2007-12-06 |
Metabolix Inc |
Dispositivos médicos e aplicações de polímeros de poli-hidroxialcanoato
|
ES2244422T3
(es)
*
|
1999-04-01 |
2005-12-16 |
Alza Corporation |
Dispositivos para la administracion transdermica de farmacos que comprenden un deposito de poliuretano para farmacos.
|
US7063859B1
(en)
|
1999-04-28 |
2006-06-20 |
Noven Pharmaceuticals, Inc. |
Barrier film lined backing layer composition and method for topical administration of active agents
|
WO2000076485A1
(fr)
*
|
1999-06-11 |
2000-12-21 |
Lintec Corporation |
Preparation sensible a l'humidite du type a absorption percutanee
|
GB2353219B
(en)
*
|
1999-08-16 |
2004-02-11 |
Johnson & Johnson Medical Ltd |
Easy to remove adhesive sheets
|
EP1212046A2
(en)
|
1999-08-30 |
2002-06-12 |
Tepha, Inc. |
Flushable disposable polymeric products
|
US6469227B1
(en)
|
1999-12-10 |
2002-10-22 |
Lectec Corporation |
Antipruritic patch
|
DE19959913A1
(de)
*
|
1999-12-11 |
2001-06-28 |
Lohmann Therapie Syst Lts |
Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
WO2003032983A1
(en)
*
|
2001-06-05 |
2003-04-24 |
Ronald Aung-Din |
Transdermal migraine therapy
|
US8329734B2
(en)
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US20060039958A1
(en)
*
|
2003-05-28 |
2006-02-23 |
Monosolrx, Llc. |
Multi-layer films having uniform content
|
US7666337B2
(en)
*
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US7910641B2
(en)
*
|
2001-10-12 |
2011-03-22 |
Monosol Rx, Llc |
PH modulated films for delivery of actives
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US20100021526A1
(en)
*
|
2001-10-12 |
2010-01-28 |
Monosol Rx, Llc |
Ph modulated films for delivery of actives
|
US20070281003A1
(en)
*
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US8765167B2
(en)
*
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US7425292B2
(en)
*
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
US20070154527A1
(en)
*
|
2001-10-12 |
2007-07-05 |
Monosoirx, Llc |
Topical film compositions for delivery of actives
|
US8017150B2
(en)
*
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
CN1665482A
(zh)
*
|
2002-04-29 |
2005-09-07 |
阿尔扎公司 |
羟可待酮控制输送给药的方法和剂型
|
KR20050034645A
(ko)
*
|
2002-05-31 |
2005-04-14 |
알자 코포레이션 |
다양한 용량의 옥시코돈을 삼투 전달하기 위한 제형 및조성물
|
CN102188409A
(zh)
*
|
2002-07-22 |
2011-09-21 |
莫诺索尔克斯有限公司 |
速溶剂型的包装和分配
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
US20050191340A1
(en)
*
|
2002-08-09 |
2005-09-01 |
Gruenenthal Gmbh |
Opioid-receptor antagonists in transdermal systems having buprenorphine
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
US20070237812A1
(en)
*
|
2006-04-11 |
2007-10-11 |
Tyco Healthcare Group |
Multi-layer wound dressings
|
US8100872B2
(en)
|
2002-10-23 |
2012-01-24 |
Tyco Healthcare Group Lp |
Medical dressing containing antimicrobial agent
|
US7202259B2
(en)
*
|
2002-11-18 |
2007-04-10 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
US20040191301A1
(en)
*
|
2003-03-27 |
2004-09-30 |
Van Duren Albert Philip |
Transdermal device having a phase change material
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
NZ542969A
(en)
*
|
2003-04-30 |
2009-09-25 |
Purdue Pharma Lp |
Tamper resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
|
US8790689B2
(en)
|
2003-04-30 |
2014-07-29 |
Purdue Pharma L.P. |
Tamper resistant transdermal dosage form
|
ES2527857T3
(es)
|
2003-05-08 |
2015-01-30 |
Tepha, Inc. |
Tejidos y fibras médicas de polihidroxialcanoato
|
US20040249364A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Ilya Kaploun |
Device and method for dispensing medication to tissue lining a body cavity
|
WO2004112723A2
(en)
|
2003-06-20 |
2004-12-29 |
Ronald Aung-Din |
Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
|
ES2395077T3
(es)
*
|
2003-07-08 |
2013-02-08 |
Tepha, Inc. |
Matrices poli-4-hidroxibutirato para una administración prolongada de medicamentos
|
AU2004268560B2
(en)
*
|
2003-08-22 |
2008-08-21 |
Tepha, Inc. |
Polyhydroxyalkanoate nerve regeneration devices
|
US20050065062A1
(en)
*
|
2003-09-24 |
2005-03-24 |
3M Innovative Properties Company |
Method of formulating a pharmaceutical composition
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
US20050234024A1
(en)
*
|
2004-04-14 |
2005-10-20 |
Clarke David E |
Materials and methods for the treatment of ulcerative colitis
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
ATE473021T1
(de)
*
|
2004-08-03 |
2010-07-15 |
Tepha Inc |
Nichtkräuselnde polyhydroxyalkanoatnähte
|
GB0417401D0
(en)
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
AR043476A1
(es)
*
|
2004-09-09 |
2005-08-03 |
Dvoskin Victor Oscar |
Dispositivo de administracion regulada de sustancias para la insercion en una cavidad corporal y procedimiento para fabricar un medio de soporte de dichas sustancias
|
US7833208B2
(en)
*
|
2004-12-29 |
2010-11-16 |
Kimberly-Clark Worldwide, Inc. |
Multilayer absorbent article
|
ES2362221T3
(es)
*
|
2005-01-28 |
2011-06-29 |
Tepha, Inc. |
Embolización con partículas poli-4-hidroxibutirato.
|
JP2006306828A
(ja)
*
|
2005-03-28 |
2006-11-09 |
Ooshin Mlp:Kk |
シート状パック化粧料及びパック化粧料用キット
|
EP1895994B1
(en)
|
2005-05-13 |
2010-08-25 |
ALZA Corporation |
Multilayer drug delivery system with barrier against reservoir material flow
|
US9056061B2
(en)
*
|
2005-09-23 |
2015-06-16 |
Alza Corporation |
Transdermal nicotine salt delivery system
|
US8383149B2
(en)
*
|
2005-09-23 |
2013-02-26 |
Alza Corporation |
High enhancer-loading polyacrylate formulation for transdermal applications
|
US20070134310A1
(en)
*
|
2005-09-23 |
2007-06-14 |
Nedberge Diane E |
Transdermal risperidone delivery system
|
ES2713062T3
(es)
|
2005-09-27 |
2019-05-17 |
Tissuetech Inc |
Preparaciones de membrana amniótica y composiciones purificadas y métodos de uso
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
WO2007059979A2
(en)
*
|
2005-11-23 |
2007-05-31 |
Universität Zürich |
Allergy treatment by epicutaneous allergen administration
|
NZ568700A
(en)
|
2005-11-28 |
2012-03-30 |
Marinus Pharmaceuticals |
Solid stabilized particulate formulations comprising ganaxolone
|
CA2632198C
(en)
*
|
2005-12-05 |
2013-10-01 |
Taro Pharmaceuticals North America, Inc. |
Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
|
JP2009523808A
(ja)
*
|
2006-01-20 |
2009-06-25 |
モノソル アールエックス リミテッド ライアビリティ カンパニー |
活性物質の粘膜投与のためのフィルム包帯
|
JP2009523672A
(ja)
*
|
2006-01-20 |
2009-06-25 |
モノソル アールエックス リミテッド ライアビリティ カンパニー |
フィルムライニングを施した、包装体およびその製法
|
AU2007209923B2
(en)
*
|
2006-01-31 |
2013-05-16 |
Covidien Lp |
Super soft foams
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
AU2007253899A1
(en)
*
|
2006-05-16 |
2007-11-29 |
Knopp Neurosciences, Inc. |
Compositions of R(+) and S(-) pramipexole and methods of using the same
|
US20070278289A1
(en)
*
|
2006-05-31 |
2007-12-06 |
Toshiba Tec Kabushiki Kaisha |
Payment adjusting apparatus and program therefor
|
GB0613333D0
(en)
*
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
GB0613638D0
(en)
*
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
MX2009000053A
(es)
*
|
2006-07-12 |
2009-02-23 |
Controlled Therapeutics Sct |
Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
|
ATE510538T1
(de)
|
2006-08-11 |
2011-06-15 |
Univ Johns Hopkins |
Zusammensetzungen und verfahren für nervenschutz
|
CA2664097A1
(en)
*
|
2006-09-20 |
2008-03-27 |
Monosol Rx, Llc |
Edible water-soluble film containing a foam reducing flavoring agent
|
ES2617150T3
(es)
|
2006-09-22 |
2017-06-15 |
Pharmacyclics Llc |
Inhibidores de tirosina cinasa de Bruton
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
AU2007354917B2
(en)
|
2006-09-26 |
2013-06-06 |
Access To Advanced Health Institute |
Vaccine composition containing synthetic adjuvant
|
AU2007305271A1
(en)
*
|
2006-09-29 |
2008-04-10 |
Monosol Rx Llc |
Film embedded packaging and method of making same
|
GB0620685D0
(en)
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
WO2008059258A2
(en)
|
2006-11-16 |
2008-05-22 |
E-Therapeutics Limited |
Imidazoles for treating multi-drug resistant bacterial infections
|
EP2101735A2
(en)
|
2006-11-28 |
2009-09-23 |
Marinus Pharmaceuticals, Inc. |
Nanoparticulate formulations and methods for the making and use thereof
|
US7943683B2
(en)
*
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
WO2008103818A1
(en)
*
|
2007-02-21 |
2008-08-28 |
University Of Louisville Research Foundation |
Therapeutic cotinine compositions
|
FR2913600B1
(fr)
*
|
2007-03-13 |
2011-02-25 |
Dbv Tech |
Dispositif pour l'application cutanee de substances.
|
US8519148B2
(en)
*
|
2007-03-14 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
CA2682200C
(en)
|
2007-03-19 |
2015-01-13 |
Vita Sciences, Llc |
Transdermal patch and method for delivery of vitamin b12
|
GB0712101D0
(en)
|
2007-06-22 |
2007-08-01 |
Therapeutics Ltd E |
Treatment of depression
|
GB0713116D0
(en)
*
|
2007-07-06 |
2007-08-15 |
Therapeutics Ltd E |
Treatment of melanoma
|
GB0714226D0
(en)
|
2007-07-20 |
2007-08-29 |
Therapeutics Ltd E |
anti-bacterial combination therapy
|
MX2010002712A
(es)
|
2007-09-10 |
2010-06-09 |
Calcimedica Inc |
Compuestos que modulan calcio intracelular.
|
AR068409A1
(es)
*
|
2007-09-14 |
2009-11-18 |
Drugtech Corp |
Composiciones farmaceuticas, transdermicas sin alcohol
|
GB0719771D0
(en)
*
|
2007-10-10 |
2007-11-21 |
Therapeutics Ltd E |
Dexanabinol in combination with inhibitors of BRAF or MEK for the treatment of melanoma
|
WO2009137631A2
(en)
*
|
2008-05-07 |
2009-11-12 |
Wintherix Llc |
Methods for identifying compounds that affect expression of cancer-related protein isoforms
|
EP2283160A4
(en)
*
|
2008-05-07 |
2012-01-04 |
Wintherix Llc |
METHOD FOR IDENTIFYING WNT SIGNALING MODULATING COMPOUNDS IN CANCER CELLS
|
US20090304776A1
(en)
*
|
2008-06-06 |
2009-12-10 |
Totada Shantha |
Transmucosal delivery of therapeutic agents and methods of use thereof
|
US7883487B2
(en)
*
|
2008-06-16 |
2011-02-08 |
Shantha Totada R |
Transdermal local anesthetic patch with injection port
|
GB0811024D0
(en)
*
|
2008-06-17 |
2008-07-23 |
E Therapeutics Plc |
Sustained release treatment of depression
|
JP2011526889A
(ja)
|
2008-06-30 |
2011-10-20 |
アフギン ファーマ,エルエルシー |
局所局部的神経作用療法
|
US8235929B2
(en)
*
|
2008-07-15 |
2012-08-07 |
Griffin Santea B |
Method of treating pruritis
|
GB0813211D0
(en)
|
2008-07-18 |
2008-08-27 |
E Therapeutics Plc |
Antibacterial combination therapy for the treatment of gram positive bacterial infections
|
KR20110071064A
(ko)
*
|
2008-08-19 |
2011-06-28 |
크놉 뉴로사이언시스 인코포레이티드 |
(r)-프라미펙솔을 사용하는 조성물 및 방법
|
US7906553B2
(en)
|
2008-08-27 |
2011-03-15 |
Calcimedica, Inc. |
Substituted thiophene modulators of intracellular calcium
|
US20100055437A1
(en)
*
|
2008-08-28 |
2010-03-04 |
Tyco Healthcare Group Lp |
Anti-microbial fibers and related articles and methods
|
US8715715B2
(en)
|
2008-11-03 |
2014-05-06 |
Nal Pharmaceuticals Ltd. |
Dosage form for insertion into the mouth
|
US8317762B2
(en)
*
|
2008-11-10 |
2012-11-27 |
Nurman Salim |
Skin patch for absorbing toxins from the body
|
US20100221313A1
(en)
*
|
2008-12-01 |
2010-09-02 |
Innovative Pharmaceuticals, Llc |
Transdermal reservoir patch
|
WO2010071866A2
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy for arthritis with tranilast
|
US20100209484A1
(en)
*
|
2009-02-13 |
2010-08-19 |
Hoo-Kyun Choi |
Transdermal Triptan Delivery System
|
DK2421901T3
(en)
|
2009-04-24 |
2016-01-11 |
Tissue Tech Inc |
Compositions comprising HC-HA complex, and methods of use thereof
|
TWI494125B
(zh)
|
2009-06-05 |
2015-08-01 |
Infectious Disease Res Inst |
合成的葡萄吡喃糖基脂質佐劑
|
AU2010262970A1
(en)
*
|
2009-06-19 |
2012-01-12 |
Knopp Neurosciences, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
GB0915877D0
(en)
|
2009-09-10 |
2009-10-14 |
E Therapeutics Plc |
Cancer cell apoptosis
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
DE102009056746A1
(de)
*
|
2009-12-04 |
2011-06-09 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System für die Verabreichung von Peptiden
|
WO2011097594A2
(en)
|
2010-02-08 |
2011-08-11 |
Kinagen, Inc. |
Therapeutic methods and compositions involving allosteric kinase inhibition
|
KR101844088B1
(ko)
|
2010-03-24 |
2018-03-30 |
아미텍 테러퓨틱 솔루션즈 인크 |
인산화효소 억제에 유용한 헤테로환 화합물
|
DK2557924T3
(da)
|
2010-04-13 |
2019-09-23 |
Relmada Therapeutics Inc |
Dermale farmaceutiske sammensætninger af 1-methyl-2',6'-pipecoloxylidid og fremgangsmåde til deres anvendelse
|
EP2558866B1
(en)
|
2010-04-15 |
2016-08-17 |
Tracon Pharmaceuticals, Inc. |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
DK2563776T3
(en)
|
2010-04-27 |
2016-09-19 |
Calcimedica Inc |
Relations that modulate intracellular calcium
|
US8754219B2
(en)
|
2010-04-27 |
2014-06-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
ES2688072T3
(es)
|
2010-05-11 |
2018-10-30 |
Mallinckrodt Ard Ip Limited |
ACTH para el tratamiento de la esclerosis lateral amiotrófica
|
NZ772688A
(en)
|
2010-06-03 |
2022-09-30 |
Pharmacyclics Llc |
The use of inhibitors of bruton’s tyrosine kinase (btk)
|
CA2807271C
(en)
|
2010-06-10 |
2018-07-31 |
Midatech Limited |
Nanoparticle film delivery systems
|
JP5916149B2
(ja)
|
2010-08-27 |
2016-05-11 |
カルシメディカ,インク. |
細胞内カルシウムを調節する化合物
|
GB201016995D0
(en)
|
2010-10-08 |
2010-11-24 |
Univ Dundee |
Cancer targets
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
US8796416B1
(en)
|
2010-10-25 |
2014-08-05 |
Questcor Pharmaceuticals, Inc |
ACTH prophylactic treatment of renal disorders
|
MY175521A
(en)
|
2011-01-07 |
2020-07-01 |
Allergan Inc |
Melanin modification compositions and methods of use
|
JP6527305B2
(ja)
|
2011-01-10 |
2019-06-05 |
インヴィオン, インコーポレイテッド |
禁煙のためのβ−アドレナリン作動性インバースアゴニストの使用
|
GB201101793D0
(en)
|
2011-02-02 |
2011-03-16 |
Univ Edinburgh |
Weight related disorders
|
NZ616304A
(en)
|
2011-04-08 |
2016-01-29 |
Immune Design Corp |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
US9526770B2
(en)
|
2011-04-28 |
2016-12-27 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
ES2822301T3
(es)
|
2011-06-10 |
2021-04-30 |
Tissuetech Inc |
Métodos de procesamiento de tejidos de soporte fetal
|
US9346803B2
(en)
|
2011-10-17 |
2016-05-24 |
Vanderbilt University |
Indomethacin analogs for the treatment of castrate-resistant prostate cancer
|
CA2795586A1
(en)
|
2011-11-15 |
2013-05-15 |
Golden Biotechnology Corporation |
Methods and compositions for treatment, modification and management of bone cancer pain
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
US20130172424A1
(en)
|
2011-12-30 |
2013-07-04 |
Golden Biotechnology Corporation |
Methods and compositions for treating diabetes
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
WO2013119856A1
(en)
|
2012-02-07 |
2013-08-15 |
Infectious Disease Research Institute |
Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
|
SE1350211A1
(sv)
|
2012-02-23 |
2013-08-24 |
Golden Biotechnology Corp |
Metoder och kompositioner för behandling av cancermetastaser
|
MX2014011473A
(es)
|
2012-03-26 |
2014-12-08 |
Golden Biotechnology Corp |
Procedimientos y composiciones de tratamiento de enfermedades vasculares arterioscleroticas.
|
GB201207305D0
(en)
|
2012-04-26 |
2012-06-13 |
E Therapeutics Plc |
Therapy
|
GB201207907D0
(en)
|
2012-05-04 |
2012-06-20 |
E Therapeutics Plc |
Treatment of depression
|
MX350274B
(es)
|
2012-05-16 |
2017-08-31 |
Immune Design Corp |
Vacunas para hsv-2.
|
EP2872181B1
(en)
|
2012-07-11 |
2020-11-18 |
Tissuetech, Inc. |
Compositions containing hc-ha/ptx3 complexes and methods of use thereof
|
US9512116B2
(en)
|
2012-10-12 |
2016-12-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
CA2892084C
(en)
|
2012-11-21 |
2020-11-10 |
Golden Biotechnology Corporation |
Methods and compositions for treating neurodegenerative diseases
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
EP2943479B1
(en)
|
2013-01-11 |
2020-04-15 |
Corsair Pharma, Inc. |
Prodrugs of treprostinil
|
TWI597061B
(zh)
|
2013-02-20 |
2017-09-01 |
國鼎生物科技股份有限公司 |
治療白血病之方法及組成物
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
MX2015012302A
(es)
|
2013-03-10 |
2016-06-21 |
Peritech Pharma Ltd |
Composiciones tópicas y métodos de tratamiento para trastornos de la piel.
|
EP2968475A2
(en)
|
2013-03-14 |
2016-01-20 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of acute respiratory distress syndrome
|
HK1214510A1
(zh)
|
2013-04-18 |
2016-07-29 |
Immune Design Corp. |
用於癌症治疗的gla单一疗法
|
WO2014188329A2
(en)
|
2013-05-20 |
2014-11-27 |
Mylan, Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
EP3838271B1
(en)
|
2013-07-12 |
2025-09-03 |
Areteia Therapeutics, Inc. |
Treating elevated levels of eosinophils and/or basophils
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
PL3033081T3
(pl)
|
2013-08-13 |
2021-08-30 |
Knopp Biosciences Llc |
Kompozycje i sposoby do leczenia przewlekłej pokrzywki
|
WO2015023786A1
(en)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
|
WO2015054283A1
(en)
|
2013-10-08 |
2015-04-16 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
CA2932609A1
(en)
|
2013-12-05 |
2015-06-11 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
WO2015112485A1
(en)
|
2014-01-21 |
2015-07-30 |
Immune Design Corp. |
Compositions for use in the treatment of allergic conditions
|
ES2792682T3
(es)
|
2014-02-10 |
2020-11-11 |
Respivant Sciences Gmbh |
Métodos para el tratamiento de enfermedades pulmonares con estabilizadores de mastocitos
|
JP2017510624A
(ja)
|
2014-02-10 |
2017-04-13 |
パタラ ファーマ リミテッド ライアビリティ カンパニー |
肥満細胞安定剤による全身性障害の治療
|
CN106414415A
(zh)
|
2014-03-14 |
2017-02-15 |
北卡罗来纳大学教堂山分校 |
用于抑制雄性生育力的小分子
|
WO2015164213A1
(en)
|
2014-04-23 |
2015-10-29 |
The Research Foundation For The State University Of New York |
A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
WO2016010538A1
(en)
|
2014-07-16 |
2016-01-21 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
EP3180040B1
(en)
|
2014-08-15 |
2020-05-13 |
Tepha, Inc. |
Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|
US9555155B2
(en)
|
2014-12-11 |
2017-01-31 |
Tepha, Inc. |
Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
TW201642914A
(zh)
|
2015-02-23 |
2016-12-16 |
組織科技股份有限公司 |
用於治療眼部疾病及失調的裝置及方法
|
WO2016138479A1
(en)
|
2015-02-27 |
2016-09-01 |
Curtana Pharmaceuticals, Inc. |
Inhibition of olig2 activity
|
BR112017018944A2
(pt)
|
2015-03-02 |
2018-05-15 |
Afgin Pharma Llc |
método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s)
|
US10383816B2
(en)
|
2015-03-02 |
2019-08-20 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with cannabinoid combination products
|
US10342831B2
(en)
|
2015-05-20 |
2019-07-09 |
Tissuetech, Inc. |
Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
|
US9643911B2
(en)
|
2015-06-17 |
2017-05-09 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
US9394227B1
(en)
|
2015-06-17 |
2016-07-19 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
US20170014417A1
(en)
|
2015-07-14 |
2017-01-19 |
Lipp Life Sciences Llc |
Pharmaceutical administration system for the transdermal application of vardenafil
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
US10238625B2
(en)
|
2015-08-07 |
2019-03-26 |
Respivant Sciences Gmbh |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
HK1257338A1
(zh)
|
2015-08-31 |
2019-10-18 |
Pharmacyclics Llc |
用於治疗多发性骨髓瘤的btk抑制剂组合
|
WO2017068349A1
(en)
|
2015-10-23 |
2017-04-27 |
E-Therapeutics Plc |
Cannabinoid for use in immunotherapy
|
CN108883308A
(zh)
|
2016-01-26 |
2018-11-23 |
利维申制药有限公司 |
α-肾上腺素能药剂的组合物和用途
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
US10851123B2
(en)
|
2016-02-23 |
2020-12-01 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US12427121B2
(en)
|
2016-05-05 |
2025-09-30 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
EP3452023A1
(en)
|
2016-05-05 |
2019-03-13 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
WO2017197240A1
(en)
|
2016-05-12 |
2017-11-16 |
The Regents Of The University Of Michigan |
Ash1l inhibitors and methods of treatment therewith
|
IL319503A
(en)
|
2016-05-16 |
2025-05-01 |
Access To Advanced Health Inst |
PEGylated liposomes and methods of use
|
EP4112638A1
(en)
|
2016-05-16 |
2023-01-04 |
Access to Advanced Health Institute |
Formulation containing tlr agonist and methods of use
|
US10821105B2
(en)
|
2016-05-25 |
2020-11-03 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
MX393217B
(es)
|
2016-06-01 |
2025-03-11 |
Infectious Disease Res Inst |
Particulas de nanoalumbre que contienen un agente de dimensionamiento
|
US10773008B2
(en)
*
|
2016-08-08 |
2020-09-15 |
Universiti Brunei Darussalam |
Medicated patch for preventing exit site infections during peritoneal dialysis
|
US20180049994A1
(en)
|
2016-08-16 |
2018-02-22 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with caryophyllene
|
MX394015B
(es)
|
2016-08-26 |
2025-03-24 |
Curtana Pharmaceuticals Inc |
Inhibición de la actividad de la olig2.
|
CA3035528A1
(en)
|
2016-08-31 |
2018-03-08 |
Respivant Sciences Gmbh |
Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
|
CA3037746A1
(en)
|
2016-10-07 |
2018-04-12 |
Respivant Sciences Gmbh |
Cromolyn compositions for treatment of pulmonary fibrosis
|
KR20230119035A
(ko)
|
2016-12-05 |
2023-08-14 |
코세어 파마 인코포레이티드 |
트레프로스티닐 및 이의 염의 피부 및 경피 투여
|
AU2018283973B2
(en)
|
2017-06-11 |
2025-04-24 |
Molecular Express, Inc. |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
CN111542318A
(zh)
|
2017-11-10 |
2020-08-14 |
密歇根大学董事会 |
Ash1l降解剂及用其进行治疗的方法
|
CN112040947A
(zh)
|
2017-12-07 |
2020-12-04 |
密歇根大学董事会 |
Nsd家族抑制剂及用其进行治疗的方法
|
CN112533581B
(zh)
|
2018-06-07 |
2024-08-30 |
密歇根大学董事会 |
Prc1抑制剂及用其进行治疗的方法
|
US10717712B2
(en)
|
2018-07-27 |
2020-07-21 |
Concentric Analgesics, Inc. |
Pegylated prodrugs of phenolic TRPV1 agonists
|
US11084825B2
(en)
|
2018-12-31 |
2021-08-10 |
Biomea Fusion, Llc |
Substituted pyridines as irreversible inhibitors of menin-MLL interaction
|
CA3133093A1
(en)
|
2019-03-15 |
2020-09-24 |
Unicycive Therapeutics, Inc. |
Nicorandil derivatives
|
US20230190680A1
(en)
|
2020-05-08 |
2023-06-22 |
Golden Biotechnology Corporation |
Methods and compositions for treating an rna virus induced disease
|
JP2023533982A
(ja)
|
2020-07-10 |
2023-08-07 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Gas41阻害剤及びその使用方法
|
WO2022133064A1
(en)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
JP2024531170A
(ja)
|
2021-08-11 |
2024-08-29 |
バイオメア フュージョン,インコーポレイテッド |
真性糖尿病に対するメニン-mll相互作用の共有結合性阻害剤
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
US20240409558A1
(en)
|
2021-09-13 |
2024-12-12 |
Biomea Fusion, Inc. |
Irreversible inhibitors of kras
|
US20250066386A1
(en)
|
2021-11-09 |
2025-02-27 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|
PE20242008A1
(es)
|
2021-12-30 |
2024-10-03 |
Biomea Fusion Inc |
Compuestos de pirazina como inhibidores de flt3
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
WO2024243402A2
(en)
|
2023-05-24 |
2024-11-28 |
Unicycive Therapeutics Inc. |
Salt forms of nicorandil derivatives
|
WO2024249950A1
(en)
|
2023-06-02 |
2024-12-05 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
US20250145571A1
(en)
|
2023-09-26 |
2025-05-08 |
Unicycive Therapeutics, Inc. |
Amino acid prodrugs of nicorandil
|
WO2025101867A1
(en)
|
2023-11-10 |
2025-05-15 |
Albert Einstein College Of Medicine |
Cell-impermeable akt inhibitors and pdpk1 inhibitors
|
WO2025194102A1
(en)
|
2024-03-15 |
2025-09-18 |
Unicycive Therapeutics, Inc. |
Pyridine modified nicorandil derivatives
|